Ukraine Strives to Remain a Hub for Clinical Trials Despite Conflict In the last couple of decades Ukraine had established itself as a thriving hub for clinical trials, especially recognized for its advancements in oncology research. Before the conflict began, the country was a beacon for international medical research, attracting increasing number of studies each year. However, the onset of the war significantly slowed this activity, Read more
Anticipating ASCO: Key Trends in Oncology Clinical Research As we approach the American Society of Clinical Oncology (ASCO) conference, the oncology community is abuzz with anticipation. Recognized as a premier event in the field, ASCO serves as a critical platform for presenting groundbreaking research, discussing innovative treatments, and sharing advancements that shape the future of cancer care. The significance of ASCO is underscored Read more
Rezdiffra Approval | Cromos Pharma
Rezdiffra Approval Sheds Light on the Challenges of NASH Diagnosis and Fibrosis Identification The recent approval of Rezdiffra (resmetirom), a novel therapeutic for the treatment of non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis, marks a significant milestone in the fight against this increasingly prevalent liver disease. However, the journey to this point underscores the persistent challenges faced by healthcare professionals in diagnosing NASH and identifying fibrosis Read more
Сlinical Trials in Georgia 2024 Georgia, a country nestled between Eastern Europe and Western Asia, has emerged as a promising destination for clinical trials. With its strategic location and favorable regulatory environment, Georgia has become increasingly attractive to international sponsors seeking to conduct innovative research projects. Since 2013, Cromos Pharma has been at the forefront of managing clinical research in Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us